NURS 6630 FINAL EXAM 5 LATEST
VERSIONS (VERSION
V1,V2,V3,V4,&V5) 2024-2025 ACTUAL
EXAM EACH EXAM CONTAINS 150
QUESTIONS AND CORRECT
ANSWERS
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines
which
of the following medications may be the best treatment option?
Selected
Answer:
C.
Atomoxetine
(Strattera) - Answer-An adult patient presents with a history of alcohol addiction and
attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines
which
of the following medications may be the best treatment option?
Selected
Answer:
C.
Atomoxetine
(Strattera
The PMHNP prescribes an obese patient phentermine (Adipex-p)/topiramate ER
(Topamax) (Qsymia), Why is topiramate (Topamax) often prescribed with phentermine
(Adipex-P)?
Selected
Answer:
B.
Phentermine (Adipex-P) works by suppressing appetite while
topiramate (Topamax) acts by inhibiting appetite - Answer-The PMHNP prescribes an
obese patient phentermine (Adipex-p)/topiramate ER
(Topamax) (Qsymia), Why is topiramate (Topamax) often prescribed with phentermine
(Adipex-P)?
Selected
Answer:
,B.
Phentermine (Adipex-P) works by suppressing appetite while
topiramate (Topamax) acts by inhibiting appetite
The PMHNP evaluates a patient presenting with symptoms of dementia. Before the
PMHNP considers treatment options, the patient must be assessed for other possible
causes of dementia. Which of the following answers addresses both possible other
causes
of dementia and a rational treatment option for Dementia?
Selected
Answer:
A.
Possible other causes: hypothyroidism, Cushing's syndrome,
multiple sclerosis
Possible treatment option: memantine - Answer-The PMHNP evaluates a patient
presenting with symptoms of dementia. Before the
PMHNP considers treatment options, the patient must be assessed for other possible
causes of dementia. Which of the following answers addresses both possible other
causes
of dementia and a rational treatment option for Dementia?
Selected
Answer:
A.
Possible other causes: hypothyroidism, Cushing's syndrome,
multiple sclerosis
Possible treatment option: memantine
The PMHNP is assessing a patient who presents with elevated levels of brain amyloid
as
noted by positron emission tomography (PET). What other factors will the PMHNP
consider before prescribing medication for this patient, and what medication would the
PMHNP want to avoid given these other factors?
Selected
Answer:
D.
Both "A" &
"B" - Answer-The PMHNP is assessing a patient who presents with elevated levels of
brain amyloid as
noted by positron emission tomography (PET). What other factors will the PMHNP
consider before prescribing medication for this patient, and what medication would the
PMHNP want to avoid given these other factors?
Selected
Answer:
D.
Both "A" &
"B"
,The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
Selected
Answer:
C.
The doses are based on achieving 60% D2
receptor occupancy - Answer-The PMHNP is discussing dopamine D2 receptor
occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
Selected
Answer:
C.
The doses are based on achieving 60% D2
receptor occupancy
The PMHNP is caring for a patient who experiences too much overstimulation and
anxiety
during daytime hours. The patient agrees to a pharmacological treatment but states, "I
don't want to feel sedated or drowsy from the medicine." Which decision made by the
PMHNP demonstrates proper knowledge of this patient's symptoms and appropriate
treatment options?
Selected A. - Answer-The PMHNP is caring for a patient who experiences too much
overstimulation and anxiety
during daytime hours. The patient agrees to a pharmacological treatment but states, "I
don't want to feel sedated or drowsy from the medicine." Which decision made by the
PMHNP demonstrates proper knowledge of this patient's symptoms and appropriate
treatment options?
Selected A.Avoiding prescribing the patient a drug that blocks
H1 receptors
Which patient will receive a lower dose of guanfacine?
Selected
Answer:
D.
Patient with kidney
disease - Answer-Which patient will receive a lower dose of guanfacine?
Selected
Answer:
D.
Patient with kidney
disease
A patient diagnosed with obsessive compulsive disorder has been taking a high-dose
, SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected
Answer:
A.
Decrease his SSRI and add buspirone
(Buspar) - Answer-A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose
SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected
Answer:
A.
Decrease his SSRI and add buspirone
(Buspar)
The PMHNP is teaching parents about their child's new prescription for Ritalin. What will
the PMHNP include in the teaching?
Selected
Answer:
A.
The second dose should be taken
at lunch - Answer-The PMHNP is teaching parents about their child's new prescription
for Ritalin. What will
the PMHNP include in the teaching?
Selected
Answer:
A.
The second dose should be taken
at lunch
The PMHNP is assessing a patient who will be receiving phentermine (Adipex-
P)/topiramate (Topamax) (Qsymia). Which of the following conditions/diseases will
require
further evaluation before this medication can be prescribed?
Selected
Answer:
C.
Cardiovascular
disease - Answer-The PMHNP is assessing a patient who will be receiving phentermine
(Adipex-
P)/topiramate (Topamax) (Qsymia). Which of the following conditions/diseases will
require
further evaluation before this medication can be prescribed?
VERSIONS (VERSION
V1,V2,V3,V4,&V5) 2024-2025 ACTUAL
EXAM EACH EXAM CONTAINS 150
QUESTIONS AND CORRECT
ANSWERS
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines
which
of the following medications may be the best treatment option?
Selected
Answer:
C.
Atomoxetine
(Strattera) - Answer-An adult patient presents with a history of alcohol addiction and
attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines
which
of the following medications may be the best treatment option?
Selected
Answer:
C.
Atomoxetine
(Strattera
The PMHNP prescribes an obese patient phentermine (Adipex-p)/topiramate ER
(Topamax) (Qsymia), Why is topiramate (Topamax) often prescribed with phentermine
(Adipex-P)?
Selected
Answer:
B.
Phentermine (Adipex-P) works by suppressing appetite while
topiramate (Topamax) acts by inhibiting appetite - Answer-The PMHNP prescribes an
obese patient phentermine (Adipex-p)/topiramate ER
(Topamax) (Qsymia), Why is topiramate (Topamax) often prescribed with phentermine
(Adipex-P)?
Selected
Answer:
,B.
Phentermine (Adipex-P) works by suppressing appetite while
topiramate (Topamax) acts by inhibiting appetite
The PMHNP evaluates a patient presenting with symptoms of dementia. Before the
PMHNP considers treatment options, the patient must be assessed for other possible
causes of dementia. Which of the following answers addresses both possible other
causes
of dementia and a rational treatment option for Dementia?
Selected
Answer:
A.
Possible other causes: hypothyroidism, Cushing's syndrome,
multiple sclerosis
Possible treatment option: memantine - Answer-The PMHNP evaluates a patient
presenting with symptoms of dementia. Before the
PMHNP considers treatment options, the patient must be assessed for other possible
causes of dementia. Which of the following answers addresses both possible other
causes
of dementia and a rational treatment option for Dementia?
Selected
Answer:
A.
Possible other causes: hypothyroidism, Cushing's syndrome,
multiple sclerosis
Possible treatment option: memantine
The PMHNP is assessing a patient who presents with elevated levels of brain amyloid
as
noted by positron emission tomography (PET). What other factors will the PMHNP
consider before prescribing medication for this patient, and what medication would the
PMHNP want to avoid given these other factors?
Selected
Answer:
D.
Both "A" &
"B" - Answer-The PMHNP is assessing a patient who presents with elevated levels of
brain amyloid as
noted by positron emission tomography (PET). What other factors will the PMHNP
consider before prescribing medication for this patient, and what medication would the
PMHNP want to avoid given these other factors?
Selected
Answer:
D.
Both "A" &
"B"
,The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
Selected
Answer:
C.
The doses are based on achieving 60% D2
receptor occupancy - Answer-The PMHNP is discussing dopamine D2 receptor
occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
Selected
Answer:
C.
The doses are based on achieving 60% D2
receptor occupancy
The PMHNP is caring for a patient who experiences too much overstimulation and
anxiety
during daytime hours. The patient agrees to a pharmacological treatment but states, "I
don't want to feel sedated or drowsy from the medicine." Which decision made by the
PMHNP demonstrates proper knowledge of this patient's symptoms and appropriate
treatment options?
Selected A. - Answer-The PMHNP is caring for a patient who experiences too much
overstimulation and anxiety
during daytime hours. The patient agrees to a pharmacological treatment but states, "I
don't want to feel sedated or drowsy from the medicine." Which decision made by the
PMHNP demonstrates proper knowledge of this patient's symptoms and appropriate
treatment options?
Selected A.Avoiding prescribing the patient a drug that blocks
H1 receptors
Which patient will receive a lower dose of guanfacine?
Selected
Answer:
D.
Patient with kidney
disease - Answer-Which patient will receive a lower dose of guanfacine?
Selected
Answer:
D.
Patient with kidney
disease
A patient diagnosed with obsessive compulsive disorder has been taking a high-dose
, SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected
Answer:
A.
Decrease his SSRI and add buspirone
(Buspar) - Answer-A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose
SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected
Answer:
A.
Decrease his SSRI and add buspirone
(Buspar)
The PMHNP is teaching parents about their child's new prescription for Ritalin. What will
the PMHNP include in the teaching?
Selected
Answer:
A.
The second dose should be taken
at lunch - Answer-The PMHNP is teaching parents about their child's new prescription
for Ritalin. What will
the PMHNP include in the teaching?
Selected
Answer:
A.
The second dose should be taken
at lunch
The PMHNP is assessing a patient who will be receiving phentermine (Adipex-
P)/topiramate (Topamax) (Qsymia). Which of the following conditions/diseases will
require
further evaluation before this medication can be prescribed?
Selected
Answer:
C.
Cardiovascular
disease - Answer-The PMHNP is assessing a patient who will be receiving phentermine
(Adipex-
P)/topiramate (Topamax) (Qsymia). Which of the following conditions/diseases will
require
further evaluation before this medication can be prescribed?
